To date, the understanding of the roles of NMRGs in immunomodulation remains limited, with preliminary preclinical findings suggesting the involvement of EDNRB [49] and C3AR1 [51] in modulating immune escape, and immune cells infiltration to tumour microenvironment in GBM. The gene discussed is C3AR1; the disease is glioblastoma.